These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6168539)

  • 1. [The use of hydroxyurea (Biosuppressin) in the accelerated phase of chronic myeloid leukemia].
    Kiss A; Jakó J; Rák K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):275-80. PubMed ID: 6168539
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy with hydroxyurea, leucopheresis and splenectomy in the treatment of chronic myeloid leukemia at the problastic phase.
    Schwarzenberg L; Mathe G; Pouillart P; Weiner R; Lacour J; Genin J; Schneider M; de Vassal F; Hayat M; Amiel JL; Schlumberger JR; Jasmin C; Rosenfeld C
    Haematologica; 1972 Apr; 57(11):601-11. PubMed ID: 4200296
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxyurea therapy in chronic myelogenous leukemia.
    Kennedy BJ
    Cancer; 1972 Apr; 29(4):1052-6. PubMed ID: 4552811
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effects of Vercyte(A-803) on chronic myelogenous leukemia].
    Kinugasa K; Takaku F; Sasa S; Mizoguchi H; Komine M
    Naika; 1971; 28(1):151-6. PubMed ID: 5284419
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy of chronic myelocytic leukemia.
    Galton DA
    Semin Hematol; 1969 Oct; 6(4):323-43. PubMed ID: 4900650
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of chronic myeloid leukemia].
    Mey U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):268-74. PubMed ID: 6168538
    [No Abstract]   [Full Text] [Related]  

  • 7. Splenic irradiation following chemotherapy in chronic myelogenous leukemia.
    Wilson JF; Johnson RE
    Radiology; 1971 Dec; 101(3):657-61. PubMed ID: 5288778
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic leukocyte oscillations in chronic myelogenous leukemia during hydroxyurea therapy.
    Kennedy BJ
    Blood; 1970 Jun; 35(6):751-60. PubMed ID: 5269413
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial of hydroxyurea in chronic myelocytic leukemia.
    Baudo F; Cattaneo N; Cipriani D; De Cataldo F; Pensabene A; Tiso R
    Haematol Lat; 1967; 10(4):359-62. PubMed ID: 5243231
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia.
    Schwartz JH; Cannellos GP
    Blood; 1975 Jul; 46(1):11-6. PubMed ID: 1055610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences in the treatment of chronic myeloid leukemia].
    Pensabene A; Panzacchi G; Cipriani D
    Haematologica; 1971; 56(3):163-8. PubMed ID: 5003589
    [No Abstract]   [Full Text] [Related]  

  • 12. Current concepts in chronic myelogenous leukemia.
    Stryckmans PA
    Semin Hematol; 1974 Apr; 11(2):101-27. PubMed ID: 4595812
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hydroxyurea in the treatment of chronic myeloid leukemia].
    Pensabene A; Cipriani D
    Haematol Lat; 1969; 12(3):767-70. PubMed ID: 5273184
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydroxyurea (Biosupressin-BIOGAL) for the treatment of chronic myelogenous leukaemia.
    Klener P; Donner L
    Ther Hung; 1981; 29(1):38-41. PubMed ID: 6964902
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic myelogenous leukemia in the dog.
    Leifer CE; Matus RE; Patnaik AK; MacEwen EG
    J Am Vet Med Assoc; 1983 Sep; 183(6):686-9. PubMed ID: 6579047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of chronic myeloid leukemia with hydroxyurea].
    Djaldetti M
    Harefuah; 1971 Nov; 81(9):438-41. PubMed ID: 5291276
    [No Abstract]   [Full Text] [Related]  

  • 17. Skin changes secondary to hydroxyurea therapy.
    Kennedy BJ; Smith LR; Goltz RW
    Arch Dermatol; 1975 Feb; 111(2):183-7. PubMed ID: 1054261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of hydroxyurea treatment on free nucleotides in leukemic leukocytes].
    Maj S; Zdebska E
    Acta Haematol Pol; 1975; 6(3):211-6. PubMed ID: 1057841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenectomy in early chronic myeloid leukaemia: preliminary report on 37 cases.
    Tura S; Baccarani M; Mandelli F; Amadori S; Cajozzo A; di Marco P; Panzacchi G; Cacciola E; Musso R; Alberti A; Magro S; Rossi Ferrini P; Leoni F; Salti F; Basetta E; Monfardini S; Buonanno G; Rizzoli V; Carnevali C; Lucarelli G; Porcellini A; Torlontano G; Fioritoni G
    Haematologica; 1974 Dec; 59(4):428-39. PubMed ID: 4219001
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience in acceleration and blastic crisis in chronic myelocytic leukemia].
    Pralle H; Löffler H
    Verh Dtsch Ges Inn Med; 1978; (84):204-6. PubMed ID: 283639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.